Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
复制标题
丝裂霉素 C 和卟啉霉素类似物,在 7 位上有取代的乙胺。
DOI:
10.1021/jm00355a004
复制
发表时间:
1983
影响因子:
7.3
通讯作者:
Schurig,JE
中科院分区:
文献类型:
--
作者:
Iyengar,BS;Sami,SM;Remers,WA;Bradner,WT;Schurig,JE
A series of 7-(2-substituted-ethyl) amino analogues of mitomycin C and porfiromycin was prepared and screened in standard antitumor systems. Certain of these analogues showed better activity than mitomycin C against P-388 leukemia, L-1210 leukemia, and/or B-16 melanocarcinoma in mice. Compounds also were tested for their leukopenic effects in mice, the limiting toxicity ofmitomycin C. Some of them were less leukopenic and some were more leukopenic than this clinical agent. No statistically significant correlations could be made betweenphysicochemical properties and antitumor activitiesof the analogues.In the preceding article in this series, we defined the goal of mitomycin analogue development as the preparation of compounds that are at least as potent and efficaceous as mitomycin C in P-388 leukemia but which cause significantly less leukopenia. New 7-substituted compounds were chosen because position 7 controls the reduction of the quinone ring, thus offering a chance to gain some selec-tivity between normal cells andcertain cancer cells. In this article, a variety of structural types were explored as substituents on the 7-amino group of mitomycin C and porfiromycin. A number of new lead compounds were identified as the targets for future analogue development, and preliminary structure-activity relationships were considered. 1